{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-013648","form_type":"8-K/A","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2025-09-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.252362+00:00","generated_at":"2026-05-17T06:29:36.165016+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Processa shareholders approve 10x authorized share increase and reverse split","bullets":["Shareholders approved increase in authorized common shares from 100M to 1B (13.7M for, 3.0M against).","Reverse stock split approved with ratio ranging from 1:2 to 1:50, at board's discretion, by Dec 31, 2026.","Amendment to 2019 Omnibus Incentive Plan to increase shares available for issuance approved (13.6M for).","All four proposals passed at special meeting held Sep 11, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-013648","json":"https://secwatch.observer/filing/0001493152-25-013648.json","markdown":"https://secwatch.observer/filing/0001493152-25-013648.md","text":"https://secwatch.observer/filing/0001493152-25-013648.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/0001493152-25-013648-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:29:36.165016+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8cdff612659746370ff4db2244d82f2c25281ac3","claim":"Processa Pharmaceuticals, Inc.: The Company filed an amendment to its Fourth Amended and Restated Certificate of Incorporation to increase authorized common stock from 100,000,000 shares to 1,000,000,000 shares (effective 2025-09-12).","evidence_excerpt":"Effective September 12, 2025, Processa Pharmaceuticals, Inc. (the “Company” or “us” or “we”) filed an amendment to its Fourth Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware to increase the number of authorized shares of common stock from 100,000,000 shares to 1,000,000,000 shares (the “Amendment”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533743/000149315225013648/0001493152-25-013648-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-09-12"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}